Clinical Trials in Cleveland

Showing 1921-1940 of 19,775 trials

miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial

NCT06285253

The clinical trial will assess the safety of miroliverELAP for the treatment of acute liver failure, severe acute alcohol-associated hepatitis, or acute on chronic liver failure. miroliverELAP is an external liver assist combination product consisting of a single-use MIRO-001 bioengineered liver graft and an extracorporeal blood circuit. miroliverELAP Is intended to support the native (failed) liver for up to 48-hours of continuous treatment to allow time for liver recovery or to identify a transplantable liver.

Acute Liver FailureAcute Liver Injury, Drug InducedAcute on Chronic Liver Failure (ACLF)+1 more

Miromatrix Medical Inc.10 participantsStarted Oct 2024

Chicago, Illinois, United States • Ann Arbor, Michigan, United States • Minneapolis, Minnesota, United States +5 more locations

COMPLETEDNA< 1 mile

Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

NCT05845710

The PERFORMANCE III study is a prospective, multicenter single-arm, open label study to evaluate the safety and effectiveness of the Neuroguard IEP® Direct System for the treatment of carotid artery stenosis in subjects at elevated risk for carotid endarterectomy (CEA). Eligible patients greater than or equal to 20 years of age and less than or equal to 82 years of age, are those who have been diagnosed with either de-novo atherosclerotic or post CEA restenotic lesion(s) in the internal carotid arteries (ICA) or at the carotid bifurcation with greater than or equal to 50% stenosis if symptomatic or greater than or equal to 70% stenosis if asymptomatic.

Carotid StenosisCarotid Artery Diseases

Contego Medical, Inc.178 participantsStarted Oct 2023

Scottsdale, Arizona, United States • Hartford, Connecticut, United States • Washington D.C., District of Columbia, United States +29 more locations

miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial

Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

Find Trials by Condition in Cleveland

Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease

Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

VIDAS® TBI Real Life Performance in Subjects With Mild Traumatic Brain Injury (mTBI)

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy

Addressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR Platform

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

ECD-Score: a Study on Erdheim-Chester Disease

A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System

Rheumatoid Arthritis Shared Decision Making

Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA